相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Implementation of an extended-infusion piperacillin-tazobactam program at an urban teaching hospital
Renee C. Xamplas et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
Cefazolin bolus and continuous administration for elective cardiac surgery: Improved pharmacokinetic and pharmacodynamic parameters
C. Adembri et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
Gita Wasan Patel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
William K. Lau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
Mohammad Reza Rafati et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
L Lorente et al.
ANNALS OF PHARMACOTHERAPY (2006)
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
JM Streit et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
TP Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia
S Jaruratanasirikul et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia
JCJ McNabb et al.
PHARMACOTHERAPY (2001)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis
BJ Angus et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)